MAGNEX is effective in FN2,3
The clinical efficacy and tolerability of cefoperazone/sulbactam are comparable to comparator drugs in the treatment of FN: Meta-analysis outcomes
Adapted from Lan SH, et al. 2020.
CI, confidence interval; FN, febrile neutropenia; OR, odds ratio.
References:
Magnex. Local product document. Pfizer; 2020. Version LPDMGX042020.
Lakshmaiah KC, Malabagi AS, Govindbabu, et al. Febrile neutropenia in hematological malignancies: clinical and microbiological profile and outcome in high-risk patients. J Lab Physicians. 2015;7(2):116-120.
Taj M, Farzana T, Shah T, et al. Clinical and microbiological profile of pathogens in febrile neutropenia in hematological malignancies: a single center prospective analysis. J Oncol. 2015;2015:596504.
Lan SH, Chang SP, Lai CC, Lu LC, Tang HJ. Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: a systemic review and meta-analysis. Medicine (Baltimore). 2020;99(8):e19321.
Please click the Prescribing Information link to view the safety and adverse events information of MAGNEX®.
For the use only of registered medical practitioner, or a hospital or a laboratory.
Abbreviation:
FN, febrile neutropenia.
1. Magnex. Local product document. Version LPDMGX042020.
2. Gan Z, Wenjie Z, Sujie P. Clinical study of cefoperazone sodium and sulbactam sodium in the treatment of severe nosocomial lower respiratory tract infections. China Modern Medicine. 2012;23:117-118.To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.
Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.
Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.